Table 4. Physicochemical Properties and Cellular Potency for Key Analogues.
Cmpd | 1 | 13 | 29 |
---|---|---|---|
LogD, TPSA, LEa | –, 100, 0.3 | 3.5, 89, 0.34 | 2.7, 86, 0.34 |
Kinetic sol. (μM) | 11 | 4 | 61 |
TMLR Ki (μM)b | 0.065 | 0.019 | 0.015 |
wtEGFR Select.c | <1× | 58× | 29× |
pEGFR H1975 EC50 (μM)b | 0.412 | 1.09 | 0.433 |
pEGFR Select. vs H292d | 5× | >23× | |
H/RLMe | 11/31 | 14/41 | 11/29 |
H/R CLhepf | 13/35 | 12,24 | 8/25 |
LE calculated using TMLR Ki.
Ki and EC50 data are an average of at least two independent experiments.
Ratio of wtEGFR Kiapp over EGFR(TMLR) Kiapp.
Ratio of pEGFR EC50 in H292 cells over pEGFR EC50 in H1975 cells.
H/RLM defined as predicted hepatic clearance in liver microsomes for human (H) and rat (R). Reported in units of mL/min/kg.
H/R CLhep defined as predicted hepatic clearance in hepatocytes for human (H) and rat (R). Reported in units of mL/min/kg.